Immunomodulating Heat-Killed Bacteria Could Become Staple Of Oncology Treatment
Insights From Immodulon CEO
Executive Summary
UK-based Immodulon Therapeutics is developing novel immunomodulators in the form of heat-killed bacteria, being trialed in combination with other cancer treatments such as checkpoint inhibitors. The biotech is initially looking at underserved areas, including pancreatic cancer.